DMPK
From early screening to IND-enabling studies, we deliver reliable data that meets global regulatory standards.
In Vivo PK and TK
Rodents
- Species and strains: Mice (CD-1, C57BL/6, Balb/c nude, etc.) (up to 2000 mice), rats (Sprague Dawley, Wistar) (up to 600 rats)
- Administration Routes:
- Oral (PO), intravenous (IV bolus, infusion), intraperitoneal (IP), subcutaneous (SC), transdermal (TD), Intratracheal (IT), Intranasal (IN), Intraduodenal (ID)
- Dose regimen: single or multiple doses
- Surgical Techniques:
- Bile-duct cannulation (BDC), jugular cannulation (JVC), portal vein cannulation (PVC)
- Biological sampling:
- Blood, plasma, serum, bile, urine, feces, cerebrospinal fluid (CSF), spinal cord sciatic nerve, specific brain region, tissue (liver, kidney, intestine, etc.) or tumor specimen
- Mouse PK: Serial bleeding
- Brain blood barrier (BBB) penetration
- Cassette-dosing (up to 5-in-1)
- Excretion pathways
Large Animals
- Species and strains: Dogs: >100 Beagle dogs, and > 40 Cynomolgus monkeys (at partner labs), Resus monkeys are also available
- Administration routes: IV bolus, IV infusion, PO (liquid, capsule, tablet), IM and SC
- Dose regimen: Single or multiple doses
- Dosing design: Crossover or non-crossover, fast or fed (food effect)
- Biological sampling: blood, plasma, serum, urine, feces and tissues, cerebrospinal fluid (CSF)
- Cassette-dosing (up to 5-in-1)
- Excretion pathways
- PK/PD evaluation
PK Study Capacity:
70 IV/PO PK studies/week
Turnaround Time:
5 working days for rodents for small molecules
5-10 working days for large animals (non-naïve) for small molecules
5-10 working days for sample bioanalysis of biologics (the entire study turnaround time is dependent on in-life sampling period)
Reprogramming Cells, Empowering Medicine
©2026 PRECEDO Biotechnology Co., Ltd. Powered by:www.300.cn